MedTrace Logo

Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie

NCT03770052 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2022-01-20

No results posted yet for this study

Summary

Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie

Conditions

Interventions

DRUG

duvie

take the intervention drug once daily according to the randomized groups

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical Corp.

    collaborator INDUSTRY

  • Pusan National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-24
Primary Completion
2021-08-19
Completion
2021-09-13

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03770052 on ClinicalTrials.gov